NCHR Comments on Prescription Drug-Use-Related Software

January 10, 2019. Digital Health is a new area of healthcare covering a broad set of technologies with diverse applications in healthcare.  The proposed risk-based framework provides an important foundation for prescription drug-use-related software, but several important issues remain.

Read More »

NCHR Comments on FDA’s Draft Guidance on Patient-Focused Drug Development

September 11, 2018. We support FDA’s efforts to increase patient engagement and input into medical product development and testing. However, we recognize how challenging it is to ensure that the information will reflect the views and experiences of a representative sample of patients. That challenge must be met in order to develop treatments that have a more meaningful impact on patients’ lives with risks that patients consider acceptable.

Read More »
Page 1 of 6312345...102030...Last »